Apyx Medical Corp. (APYX)
2.645
-0.04
(-1.67%)
USD |
NASDAQ |
Oct 30, 11:21
Apyx Medical EPS Diluted (Quarterly) : -0.074 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.074 |
| March 31, 2026 | -0.0482 |
| December 31, 2025 | -0.0308 |
| September 30, 2025 | -0.0487 |
| June 30, 2025 | -0.0928 |
| March 31, 2025 | -0.1019 |
| December 31, 2024 | -0.1211 |
| September 30, 2024 | -0.1358 |
| June 30, 2024 | -0.1892 |
| March 31, 2024 | -0.2187 |
| December 31, 2023 | -0.2773 |
| September 30, 2023 | -0.1336 |
| June 30, 2023 | -0.0287 |
| March 31, 2023 | -0.1007 |
| December 31, 2022 | -0.1748 |
| September 30, 2022 | -0.1667 |
| June 30, 2022 | -0.1574 |
| March 31, 2022 | -0.1727 |
| December 31, 2021 | -0.0583 |
| September 30, 2021 | -0.123 |
| June 30, 2021 | -0.1179 |
| March 31, 2021 | -0.143 |
| December 31, 2020 | -0.0446 |
| September 30, 2020 | -0.1091 |
| June 30, 2020 | -0.1372 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0571 |
| December 31, 2019 | -0.159 |
| September 30, 2019 | -0.1282 |
| June 30, 2019 | -0.1286 |
| March 31, 2019 | -0.1682 |
| December 31, 2018 | -0.0976 |
| September 30, 2018 | -0.0181 |
| June 30, 2018 | -0.0083 |
| March 31, 2018 | -0.0284 |
| December 31, 2017 | -0.0251 |
| September 30, 2017 | -0.0401 |
| June 30, 2017 | -0.04 |
| March 31, 2017 | -0.06 |
| December 31, 2016 | -0.0205 |
| September 30, 2016 | -0.04 |
| June 30, 2016 | -0.02 |
| March 31, 2016 | -0.07 |
| December 31, 2015 | -0.05 |
| September 30, 2015 | -0.06 |
| June 30, 2015 | -0.06 |
| March 31, 2015 | 0.57 |
| December 31, 2014 | -0.2678 |
| September 30, 2014 | -0.17 |
| June 30, 2014 | -0.07 |
| March 31, 2014 | -0.55 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.5293 |
| AngioDynamics, Inc. | -0.1689 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
| Baxter International, Inc. | 0.00 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.072M |
| Revenue (Quarterly) | 13.88M |
| Total Expenses (Quarterly) | 17.13M |
| Enterprise Value | 125.73M |
| Gross Profit Margin (Quarterly) | 39.59% |
| Profit Margin (Quarterly) | -22.13% |
| Earnings Yield | -7.63% |
| Normalized Earnings Yield | -7.622 |